Seres Therapeutics MCRB
NASDAQ MCRB
$2.40 +0.09 (+3.90%)
As of: Oct 21, 2026 · 9:56 AM EDT

Seres Therapeutics (MCRB) Raw Materials (2023 - 2024)

Updated

Seres Therapeutics' Raw Materials came in at $4.93 million for Q2 2024, up 802.0% from $547,000 a year earlier and up 16.8% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Raw Materials (2023 - 2024) Analysis & Trends

At the end of FY2023, Seres Therapeutics' Raw Materials was $4.43 million.

  • Business Quant data shows MCRB's Raw Materials at $4.22 million (Q1 2024), $4.43 million (Q4 2023) and $3.53 million (Q3 2023) in the three quarters before Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.43 Bn 1,102.02 Bn 19.71 Bn
2 Johnson & Johnson 615.31 Bn 533.83 Bn 17.26 Bn
3 AbbVie 505.93 Bn 479.05 Bn 12.70 Bn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn
7 Amgen 236.28 Bn 191.68 Bn 7.24 Bn
8 Gilead Sciences 190.31 Bn 164.51 Bn 6.22 Bn
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn
10 Seres Therapeutics 23.29 Mn -115.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 4.93 Mn
Mar 31, 2024 4.22 Mn
Dec 31, 2023 4.43 Mn
Sep 30, 2023 3.53 Mn
Jun 30, 2023 547,000.00
API Access

Seres Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=MCRB&period=max&api_key=YOUR_API_KEY